Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

QbD vs Troubleshooting

Reducing time to market is one of the ultimate goals for every pharmaceutical lab.

Being the first on the market brings a competitive advantage for prescription, over-the-counter (OTC), or generic drug manufacturers. Applying quality-by-design (QbD) principles at the formulation phase can prevent tablet defects at an early stage and thereby drastically reduce time during the complex and troublesome phase of scale-up.

Waiting until late in development in the production-size phase may force scientists to solve formulation issues at the pilot level or even worse in actual production. A QbD approach secures the scale-up to production with maximum safety right from the beginning.

Download to find out more.


Go Top